Summary: Nonin Medical and Corscience have partnered to co-promote their respective SpO2 and CO2 monitoring solutions. The collaboration aims to address growing demand in the US and Europe for advanced patient monitoring technologies and improve patient outcomes by combining their expertise in pulse oximetry and capnography.

Key Takeaways:

  • Strategic Partnership: Nonin and Corscience join forces to expand market reach.
  • Joint Technologies: Complementary SpO2 and CO2 monitoring solutions enhance patient monitoring.
  • Focus on Healthcare: Aiming to improve outcomes for cardiovascular and respiratory patients.

Nonin Medical, a provider of SpO2 monitoring solutions, and Corscience, a provider of CO2 monitoring solutions, have entered into a partnership to co-promote each other’s OEM product offerings. The two manufacturers are collaborating to better serve both the US and European markets with the highest quality patient monitoring offerings.

Growing Demand for Respiratory and Cardiovascular Monitoring Solutions

The demand for high-quality OEM components for respiratory and cardiovascular disease monitoring devices is increasing, according to the companies.

“As the challenges of global healthcare become increasingly complex, we recognize the urgency and need for innovative solutions,” said Dr. Jörg Pintaske, CEO of Corscience, on the occasion of the announcement of the strategic partnership. “This partnership brings together specialists in pulse oximetry and capnography who will use their combined sales channels to promote high-quality monitoring modules and devices to customers and, most importantly, to caregivers around the world.”

Increasing Threat from Cardiovascular Disease

The American Heart Association classifies cardiovascular disease as one of the greatest threats to the population in the US. Last year, 41% of all deaths in the US were due to cardiovascular disease, followed by associated diseases such as strokes, high blood pressure, and vascular disease. According to studies by the European Society of Cardiology (ESC), the figure in Europe is as high as 45%.

Monitoring systems with precise capnography and pulse oximetry measurements can counteract these figures and save lives, according to the partnering companies, emphasizing the reason for their joint venture.

Joint Technologies for Patient Monitoring

Corscience’s CO2 monitoring solution and Nonin’s SpO2 monitoring solutions are designed to be complementary, and both companies expect to expand their market presence through this co-promotion partnership. Corscience will be able to extend its market presence with the CAP capnography module (available options for emergency, clinical, and magnetic resonance imaging environments) in North America and other markets in the future, while Nonin Medical expects to expand its SpO2 monitoring solutions worldwide.

“Nonin’s mission is to improve the lives of patients through noninvasive monitoring and we are excited to partner with Corscience. This partnership will expand access to high-quality capnography and pulse oximetry devices helping improve patient outcomes,” explains John Hastings, CEO of Nonin Medical.